- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
The role of CD180 in hematological malignancies and inflammatory disorders ; volume:29 ; number:1 ; day:17 ; month:7 ; year:2023 ; pages:1-22 ; date:12.2023
Molecular medicine ; 29, Heft 1 (17.7.2023), 1-22, 12.2023
- Urheber
-
Edwards, Kurtis
Lydyard, Peter M.
Kulikova, Nino
Tsertsvadze, Tamar
Volpi, Emanuela V.
Chiorazzi, Nicholas
Porakishvili, Nino
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s10020-023-00682-x
- URN
-
urn:nbn:de:101:1-2023102409102301059634
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Edwards, Kurtis
- Lydyard, Peter M.
- Kulikova, Nino
- Tsertsvadze, Tamar
- Volpi, Emanuela V.
- Chiorazzi, Nicholas
- Porakishvili, Nino
- SpringerLink (Online service)
Ähnliche Objekte (12)
Role of CD47 in Hematological Malignancies
Deubiquitinases in hematological malignancies
Checkpoint inhibitors in hematological malignancies
Rac GTPases in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies
Targeting immune checkpoints in hematological malignancies
Cellular immunotherapy for refractory hematological malignancies
IL-31, itch and hematological malignancies
Targeting splicing for hematological malignancies therapy
The role of proteostasis in hematological malignancies and the therapeutic implications
Targeting posttranslational modifications to treat hematological malignancies
Role of CD47 in Hematological Malignancies
Deubiquitinases in hematological malignancies
Checkpoint inhibitors in hematological malignancies
Rac GTPases in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies
Targeting immune checkpoints in hematological malignancies
Cellular immunotherapy for refractory hematological malignancies
IL-31, itch and hematological malignancies
Targeting splicing for hematological malignancies therapy
The role of proteostasis in hematological malignancies and the therapeutic implications
Targeting posttranslational modifications to treat hematological malignancies
Role of CD47 in Hematological Malignancies
Deubiquitinases in hematological malignancies
Checkpoint inhibitors in hematological malignancies
Rac GTPases in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies
Targeting immune checkpoints in hematological malignancies
Cellular immunotherapy for refractory hematological malignancies
IL-31, itch and hematological malignancies
Targeting splicing for hematological malignancies therapy
The role of proteostasis in hematological malignancies and the therapeutic implications